Nigral dopamine type-1 receptors are reduced in Huntington's disease: A postmortem autoradiographic study using [3H]SCH 23390 and correlation with [3H]forskolin binding
- 1 November 1990
- journal article
- research article
- Published by Elsevier BV in Experimental Neurology
- Vol. 110 (2), 219-227
- https://doi.org/10.1016/0014-4886(90)90033-o
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Presymptomatic diagnosis of delayed-onset disease with linked DNA markers. The experience in Huntington's diseasePublished by American Medical Association (AMA) ,1989
- PET and movement disorders.Journal of Neurology, Neurosurgery & Psychiatry, 1989
- Positron emission tomographic scan investigations of Huntington's disease: Cerebral metabolic correlates of cognitive functionAnnals of Neurology, 1988
- Differential sensitivity of neuropeptide Y, somatostatin and NADPH-diaphorase containing neurons in rat cortex and striatum to quinolinic acidBrain Research, 1988
- Quinolinic acid does not spare striatal neuropeptide Y-immunoreactive neuronsBrain Research, 1987
- D-1 dopamine receptor changes after striatal quinolinic acid lesionEuropean Journal of Pharmacology, 1987
- Replication of the neurochemical characteristics of Huntington's disease by quinolinic acidNature, 1986
- Clinical correlates of dementia and disability in Huntington's diseaseJournal of Clinical Neuropsychology, 1984
- The brain in Huntington's choreaPsychological Medicine, 1978
- Lesion of striatal neurons with kainic acid provides a model for Huntington's choreaNature, 1976